Augmentation of anti-Candida activity of neutrophils by macrophages treated with itraconazole

• Published in: Nihon Ishinkin Gakkai zasshi Vol. 39; no. 1; pp. 17 - 25
• Main Authors: Hara, E, Ishijima, S A, Ochi, H, Osumi, M, Abe, S, Yamaguchi, H
• Format: Journal Article
• Language: Japanese
• Published: Japan 1998
• Subjects: Animals; Antifungal Agents - pharmacology; Candida albicans - drug effects; Candida albicans - growth & development; Candida albicans - ultrastructure; Itraconazole - pharmacology; Macrophages - metabolism; Macrophages - physiology; Mice; Microscopy, Electron, Scanning; Neutrophils - physiology; Tumor Necrosis Factor-alpha - biosynthesis; Tumor Necrosis Factor-alpha - pharmacology
• ISSN: 0916-4804
• DOI: 10.3314/jjmm.39.17

Effects of itraconazole (ITCZ) on anti-Candida activity of a macrophage (MP)-neutrophil axis were examined in vitro. Murine peritoneal MP, stimulated by an enterococcal preparation FK-23, released tumor necrosis factor a (TNF) into the culture medium in 20 hr-culture period. This level of TNF production by the stimulated MP, which were measured by a bioassay or immunological assay, was heightened by co-stimulation with 0.5 mg/ml of ITCZ. Supernatants obtained from the culture medium of FK-23 and ITCZ-treated MP not only contained about 10 ng/ml of TNF but also had the capacity to enhance anti-Candida activity of murine neutrophils. This enhancement was blocked by pretreatment of the MP-supernatant with anti-TNF antibody. Observation by scanning electron microscope suggested that cell walls of the candida mycelia, the growth of which was inhibited by the neutrophils in the presence of either the MP-supernatant or TNF, sustained similar structural damage. These results suggest that ITCZ augments anti-Candida activity of neutrophils through enhanced production of TNF by MP in vitro.